Targeting CDK1 in cancer: mechanisms and implications
Cyclin dependent kinases (CDKs) are serine/threonine kinases that are proposed as
promising candidate targets for cancer treatment. These proteins complexed with cyclins …
promising candidate targets for cancer treatment. These proteins complexed with cyclins …
[HTML][HTML] Biological functions of CDK5 and potential CDK5 targeted clinical treatments
A Shupp, MC Casimiro, RG Pestell - Oncotarget, 2017 - ncbi.nlm.nih.gov
Cyclin dependent kinases are proline-directed serine/threonine protein kinases that are
traditionally activated upon association with a regulatory subunit. For most CDKs, activation …
traditionally activated upon association with a regulatory subunit. For most CDKs, activation …
CDK9: a comprehensive review of its biology, and its role as a potential target for anti-cancer agents
AT Anshabo, R Milne, S Wang, H Albrecht - Frontiers in oncology, 2021 - frontiersin.org
Cyclin-dependent kinases (CDKs) are proteins pivotal to a wide range of cellular functions,
most importantly cell division and transcription, and their dysregulations have been …
most importantly cell division and transcription, and their dysregulations have been …
Targeting CDK2 in cancer: challenges and opportunities for therapy
Highlights•CDK2 has key roles in cell cycle, DNA replication and DNA damage.•Multiple
biomarkers can indicate increased CDK2 activity.•Some cancers have particular …
biomarkers can indicate increased CDK2 activity.•Some cancers have particular …
Targeting CDK12 for cancer therapy: function, mechanism, and drug discovery
H Liu, K Liu, Z Dong - Cancer research, 2021 - AACR
Abstract Cyclin-dependent kinase 12 (CDK12) is a member of the CDK family of proteins
(CDK) and is critical for cancer development. Years of study into CDK12 have generated …
(CDK) and is critical for cancer development. Years of study into CDK12 have generated …
CDK8 kinase—An emerging target in targeted cancer therapy
Cyclin-dependent kinase (CDK) inhibitors have been developed as potential anticancer
therapeutics and several nonselective compounds are currently in advanced clinical trials …
therapeutics and several nonselective compounds are currently in advanced clinical trials …
Targeting CDK6 in cancer: State of the art and new insights
S Tadesse, M Yu, M Kumarasiri, BT Le, S Wang - Cell Cycle, 2015 - Taylor & Francis
Cyclin-dependent kinase 6 (CDK6) plays a vital role in regulating the progression of the cell
cycle. More recently, CDK6 has also been shown to have a transcriptional role in tumor …
cycle. More recently, CDK6 has also been shown to have a transcriptional role in tumor …
Cyclin-dependent kinase 2 inhibitors in cancer therapy: an update
Cyclin-dependent kinase 2 (CDK2) drives the progression of cells into the S-and M-phases
of the cell cycle. CDK2 activity is largely dispensable for normal development, but it is …
of the cell cycle. CDK2 activity is largely dispensable for normal development, but it is …
Cyclin-dependent kinase 8: A new hope in targeted cancer therapy? Miniperspective
S Philip, M Kumarasiri, T Teo, M Yu… - Journal of medicinal …, 2017 - ACS Publications
Cyclin-dependent kinase 8 (CDK8) plays a vital role in regulating transcription either
through its association with the Mediator complex or by phosphorylating transcription factors …
through its association with the Mediator complex or by phosphorylating transcription factors …